CAM
CNMD icon

Cresset Asset Management’s CONMED CNMD Stock Holding History

Cresset Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,517
Closed -$398K – 1853
2024
Q3 		$398K Buy
5,517
+1,495
+37% +$105K ﹤0.01% 1653
2024
Q2 		$280K Buy
4,022
+1,032
+35% +$75.3K ﹤0.01% 1749
2024
Q1 		$240K Sell
2,990
-511
-15% -$45.5K ﹤0.01% 1687
2023
Q4 		$384K Buy
3,501
+302
+9% +$31.2K ﹤0.01% 1371
2023
Q3 		$323K Buy
3,199
+379
+13% +$43.5K ﹤0.01% 1407
2023
Q2 		$384K Buy
+2,820
New +$344K ﹤0.01% 1407
2019
Q2 		– Sell
-60
Closed -$5K – 707
2019
Q1 		$5K Buy
60
+3
+5% +$218 ﹤0.01% 1356
2018
Q4 		$4K Buy
+57
New +$3.9K ﹤0.01% 1079

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Cresset Asset Management's CNMD Position: Q4 2024 in Review

Cresset Asset Management sold out of CONMED (CNMD) in Q4 2024, closing a stake of 5,517 shares — an estimated $398K sold.

Cresset Asset Management first reported a position in CNMD in Q4 2018 and held it in 8 quarters. The position peaked at $398K in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Cresset Asset Management reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 5,517 CONMED shares in Q4 2024, an estimated $398K.
  • Cresset Asset Management first reported a position in CONMED in Q4 2018 and held it in 8 quarters.
  • Cresset Asset Management's CONMED position peaked at $398K in Q3 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.